Article
SL4, a chalcone‐based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway
26 Oct 2015
Abstract excerpt
OBJECTIVES: SL4, a chalcone-based compound, exhibits clearly inhibitory effects on HIF-1 and has been shown to effectively suppress tumour invasion and angiogenesis in vitro and in vivo. Here, studies were conducted to determine SL4's anti-apoptotic effects and its underlying mechanisms, in human cancer cells. MATERIALS AND METHODS: Cytotoxicity, apoptotic induction and its involved mechanisms of SL4 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
